| Objective: Attention Deficit/Hyperactivity Disorder (ADHD) is a growing public health concern as it is one of the most increasingly prevalent mental disorders in children, which will often persist into adulthood. Symptoms and impairments associated with ADHD result in an increased cost burden on the education, health and justice systems and/or a loss of productivity and wages. This dissertation reviews the clinical efficacy of neurofeedback as an alternative to the current gold standard of treatment with stimulant medications.;Methods: Systematic searches for U.S. based incremental cost studies for individuals diagnosed with ADHD, and their families was conducted, followed by a second systematic search for the effects of neurofeedback on three core symptoms of ADHD including inattention, hyperactivity and impulsiveness.;Results: Total annual national incremental costs related to ADHD ranged from ;Conclusion: Despite wide ranges in reported incremental cost estimates, ADHD has a substantial and escalating economic impact on the United States. Neurofeedback may be a legitimate, scientific and evidence-based intervention for the treatment of ADHD. These findings are important to future policy direction and the existing body of research. |
